Krystal Biotech (KRYS)
(Delayed Data from NSDQ)
$161.10 USD
+0.87 (0.54%)
Updated May 3, 2024 04:00 PM ET
After-Market: $160.86 -0.24 (-0.15%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/06/2024
Time: BMO |
3/2024 | $0.20 | 2.56% |
Earnings Summary
For their last quarter, Krystal Biotech (KRYS) reported earnings of $0.30 per share, beating the Zacks Consensus Estimate of $-0.52 per share. This reflects a positive earnings surprise of 157.69%. Look out for KRYS's next earnings release on May 06, 2024. For the next earning release, we expect the company to report earnings of $0.20 per share, reflecting a year-over-year increase of 111.36%.
Earnings History
Price & Consensus
Zacks News for KRYS
Down -7.21% in 4 Weeks, Here's Why Krystal Biotech (KRYS) Looks Ripe for a Turnaround
KRYS: What are Zacks experts saying now?
Zacks Private Portfolio Services